DMARDs: What Impact Do They Have on COVID-19 Outcomes in RA?

Rheum Advisor on Air
29/06/2021 13 min Temporada 1 Episodio 24
DMARDs: What Impact Do They Have on COVID-19 Outcomes in RA?

Listen "DMARDs: What Impact Do They Have on COVID-19 Outcomes in RA?"

Descargar episodio Ver en sitio original

Episode Synopsis

In the first episode of the European Alliance of Associations for Rheumatology (EULAR) 2021 Virtual Congress series, we spoke with co-authors Jeffrey Sparks, MD, and Zachary Wallace, MD, about their research – the association between disease-modifying antirheumatic drug (DMARD) use and COVID-19 outcomes in rheumatoid arthritis (RA) – conducted on behalf of the COVID-19 Global Rheumatology Alliance. The study was presented by Dr Sparks and Dr Wallace at the EULAR 2021 meeting and has been published in BMJ. 

More episodes of the podcast Rheum Advisor on Air

Gout Management at the Intersection of Primary Care and Rheumatology 21/06/2023
Sleep Disorders in Rheumatic Diseases: A Wake-Up Call 20/04/2023
A Shot in the Arm: COVID-19 Vaccine Safety in Autoimmune Rheumatic Diseases 22/03/2023
COVID-19 Vaccine Hesitancy: What Your Patients Want You to Know 08/02/2023
Advancing Global Rheumatology Research – It Takes a Joint Effort 17/01/2023
Legal Considerations for Telemedicine Practice in a Post-Pandemic World 24/08/2022
Gout Among Women: Not Just a "Man's Disease" 20/05/2022
It's About Time We Took Chronic Pain Seriously 29/04/2022
The Elephant in the Rheum – "Burnout" Among the Workforce 24/03/2022
In Rare We Care: Pediatric Rheumatic Disease Awareness & Management 25/02/2022
© 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA